# Frankincense (Boswellia sacra) **Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/frankincense **Data Source:** Hermetica Superfoods Ingredient Encyclopedia **Updated:** 2026-03-30 **Evidence Score:** 2 / 10 **Category:** Middle Eastern **Also Known As:** Olibanum, Sacred frankincense, Omani frankincense, Arabian frankincense, Luban, Lubaan, Boswellia sacra resin, Holy incense, White frankincense, Silver frankincense, Hojari frankincense ## Overview Frankincense (Boswellia sacra) contains boswellic acids, particularly acetyl-11-keto-β-boswellic acid (AKBA), which inhibit 5-lipoxygenase (5-LOX) to reduce leukotriene synthesis and dampen [inflammatory](/ingredients/condition/inflammation) cascades. Most supporting evidence derives from in vitro and animal models, with limited but promising human clinical data for inflammatory conditions. ## Health Benefits • Potential [antimicrobial](/ingredients/condition/immune-support) and [antioxidant](/ingredients/condition/antioxidant) properties from in vitro studies, though human data is lacking. • Boswellic acids may inhibit 5-lipoxygenase, suggesting [anti-inflammatory](/ingredients/condition/inflammation) potential, based on chemical studies. • Historical use in Middle Eastern traditional medicine for various ailments. • Utilized in cosmetics and perfumes for its aromatic properties. • Preliminary studies highlight boswellic acids' potential benefits, but human trials are needed. ## Mechanism of Action Acetyl-11-keto-β-boswellic acid (AKBA) selectively inhibits 5-lipoxygenase (5-LOX), blocking the conversion of arachidonic acid into pro-inflammatory leukotrienes such as LTB4. Boswellic acids also suppress NF-κB activation, reducing downstream transcription of cytokines including TNF-α and IL-1β. Additionally, AKBA has been shown to inhibit human leukocyte elastase (HLE), potentially contributing to its [anti-inflammatory](/ingredients/condition/inflammation) and tissue-protective effects. ## Clinical Summary Most human evidence for Boswellia sacra specifically is sparse; the bulk of clinical trials use Boswellia serrata extracts standardized to AKBA. A small randomized trial in osteoarthritis patients (n=30) using a Boswellia extract reported a statistically significant reduction in pain scores and improved mobility over 8 weeks compared to placebo. In vitro studies consistently demonstrate 5-LOX inhibition at micromolar AKBA concentrations, though translation to human therapeutic outcomes remains incompletely established. Overall, the evidence base is preliminary and larger, well-controlled trials specific to Boswellia sacra are needed before firm efficacy conclusions can be drawn. ## Nutritional Profile Frankincense (Boswellia sacra) resin is not consumed as a conventional food ingredient and thus lacks a standard nutritional profile in terms of macronutrients. However, its chemical composition is well-characterized: Primary bioactive compounds are pentacyclic triterpenic boswellic acids, comprising approximately 25–35% of the resin by dry weight, with key constituents including β-boswellic acid, acetyl-β-boswellic acid (AβBA), 11-keto-β-boswellic acid (KBA), and acetyl-11-keto-β-boswellic acid (AKBA), the latter present at roughly 1–5% and considered most pharmacologically potent. The essential oil fraction constitutes approximately 5–9% of the resin and contains monoterpenes (α-pinene ~40–60% of oil fraction, limonene ~3–8%, p-cymene ~2–5%), sesquiterpenes (incensole acetate ~2–10%), and diterpenes. Polysaccharides (arabinogalactans) make up approximately 15–20% of the resin. Macro- and micronutrient content (carbohydrates, proteins, fats, vitamins, minerals) is negligible given that frankincense is used in trace aromatic or supplemental doses, not as a dietary staple. Bioavailability of boswellic acids is limited by poor oral absorption; lipophilic delivery formulations (e.g., with lecithin) have been shown in studies to increase plasma AKBA levels by up to 5-fold compared to standard extracts. Typical oral supplement doses studied range from 300–1200 mg of standardized extract daily. ## Dosage & Preparation No clinically studied dosage ranges for Boswellia sacra are specified, as human clinical data is absent. Consult a healthcare provider before starting any new supplement. ## Safety & Drug Interactions Boswellia sacra is generally well tolerated at typical doses (300–500 mg extract daily), with the most commonly reported adverse effects being mild gastrointestinal upset, nausea, and diarrhea. Due to its [anti-inflammatory](/ingredients/condition/inflammation) mechanism involving arachidonic acid pathways, concurrent use with NSAIDs or anticoagulants such as warfarin warrants caution, as additive effects on bleeding risk are theoretically possible. Pregnant and breastfeeding women should avoid use, as some animal data suggest uterine-stimulating activity and safety in human pregnancy has not been established. Individuals with liver conditions should consult a physician before use, as rare cases of hepatotoxicity have been reported with concentrated Boswellia preparations. ## Scientific Research There is a lack of specific human clinical trials, RCTs, or meta-analyses for Boswellia sacra frankincense. The research primarily consists of in vitro studies focusing on chemical composition and potential properties. ## Historical & Cultural Context Frankincense has been traditionally used in Middle Eastern medicine, especially in Oman, for treating various ailments. It is also highly valued in the commercial production of cosmetics, food flavors, and perfumes. ## Synergistic Combinations Turmeric, Black Pepper, Ginger, Ashwagandha, Ginkgo Biloba ## Frequently Asked Questions ### What is the active compound in Boswellia sacra responsible for its anti-inflammatory effects? The primary bioactive compound is acetyl-11-keto-β-boswellic acid (AKBA), which selectively inhibits the enzyme 5-lipoxygenase (5-LOX) at micromolar concentrations. This blocks leukotriene synthesis from arachidonic acid, reducing a key driver of chronic inflammation distinct from the COX pathway targeted by NSAIDs. ### How does Boswellia sacra differ from Boswellia serrata? Boswellia sacra is native to the Arabian Peninsula and the Horn of Africa and is the species traditionally harvested for sacred frankincense resin, while Boswellia serrata originates from India and is the species most extensively studied in clinical trials for inflammatory conditions. Both contain boswellic acids including AKBA, but their exact phytochemical profiles, resin compositions, and clinical evidence bases differ; most published human trial data applies to Boswellia serrata extracts rather than Boswellia sacra specifically. ### What dose of Boswellia sacra is typically used in studies? Clinical studies on Boswellia species most commonly use standardized extracts providing 100–400 mg of boswellic acids per day, often in doses of 300–500 mg of extract taken two to three times daily. Extracts are frequently standardized to contain at least 30–65% boswellic acids, with AKBA content sometimes specified at 10% or higher for therapeutic relevance. No dose has been formally established for Boswellia sacra in isolation due to limited species-specific human trials. ### Can Boswellia sacra be taken with ibuprofen or other NSAIDs? Combining Boswellia with NSAIDs like ibuprofen is theoretically possible but should be done cautiously and under medical supervision, as both target inflammatory pathways—Boswellia via 5-LOX and NSAIDs via COX-1/COX-2—and concurrent use may amplify gastrointestinal irritation or alter anti-inflammatory effects unpredictably. No large human pharmacokinetic interaction studies have formally characterized this combination. Patients on chronic NSAID therapy should disclose Boswellia use to their healthcare provider. ### Is frankincense from Boswellia sacra safe to use during pregnancy? Boswellia sacra is not considered safe during pregnancy and is generally contraindicated. Animal studies have indicated potential uterine-stimulating properties of boswellic acid fractions, raising concern for increased risk of miscarriage or premature labor. No controlled human safety data in pregnant populations exists, and regulatory bodies and herbalists consistently advise against its use throughout pregnancy and lactation. ### What is the difference between frankincense resin extract and frankincense essential oil supplements? Frankincense resin extracts (standardized to boswellic acids) are designed for oral supplementation and contain the active compounds studied for anti-inflammatory effects, while essential oils are primarily volatile aromatic compounds used topically or aromatically and lack significant boswellic acid content. Resin extracts are the form used in clinical research for joint and digestive health, whereas essential oils are better suited for cosmetic and aromatic applications. For therapeutic benefits targeting inflammation, standardized resin extracts are the more appropriate choice based on available evidence. ### How does Boswellia sacra's antimicrobial potential compare to other herbal antimicrobials based on current research? In vitro studies suggest Boswellia sacra exhibits antimicrobial activity against certain bacteria and fungi, though human clinical trials demonstrating clinical efficacy are currently lacking. Most antimicrobial research on Boswellia sacra remains preliminary and conducted in laboratory settings rather than in human populations. Compared to well-established antimicrobials like goldenseal or oregano oil, Boswellia sacra has substantially less human evidence supporting antimicrobial claims, making it better validated for anti-inflammatory rather than antimicrobial applications. ### Are there quality or purity concerns specific to Boswellia sacra supplements from different geographic sources? Boswellia sacra is native to Oman and Yemen, and resin sourced from these regions may vary in boswellic acid content and purity depending on harvest methods and processing standards. Supplements standardized to specific boswellic acid percentages (typically 30–65%) offer more consistent quality than non-standardized frankincense powders, which may contain fillers or lower-potency resin. When selecting a Boswellia sacra supplement, third-party testing and standardization verification help ensure you are receiving the ingredient concentration used in clinical studies. --- *Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com* *License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*